LDL-c & PCSK9 inhibition in high CV risk patients
Report on expert meeting on LDL-c & PCSK9 inhibition in high CV risk patients
Episodes 1-7 of 7
- LDL-c & PCSK9i in Clinical CardiologyWhat are the key issues and challenges impacting clinical management with novel therapeutics lowering cholesterol?